Arena's (ARNA) Lorcaserin Becomes First Weight-Loss Drug Approved in 13 Years
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
With approval, Arena Pharmaceuticals' (Nasdaq: ARNA) lorcaserin (Belviq) becomes first weight-loss drug approved in 13 years. Shares are currently halted.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- Scorpion Capital says short Twist Biosciences
- Deere conference call: 2027 orders up mid-single digits from last year)
Create E-mail Alert Related Categories
FDA, Insiders' Blog, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
